Concepedia

Publication | Open Access

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

DOIFull Paper Access

73

Citations

36

References

2014

Year

Teri Liegler, Mohamed Abdel‐Mohsen, L. Gordon Bentley, Robert E. Atchison, Timothy M. Schmidt, Jacqueline Javier, Megha Mehrotra, Christopher Eden, David V. Glidden, Vanessa McMahan,
The Journal of Infectious Diseases

Abstract

Drug resistance was rare in iPrEx on-study FTC/TDF-randomized seroconverters, and only as low-frequency minor variants. FTC resistance among those initiating PrEP with acute infection waned rapidly after drug discontinuation. Clinical Trials Registration.NCT00458393.

References

YearCitations

Page 1